fbpx
August 13, 2021

MS Treatment Choice May Influence Depression Risk MS Treatment Choice May Influence Depression Risk

The choice of treatment for multiple sclerosis (MS) may influence depression risk in this patient population, new research suggests. Investigators found that the monoclonal antibody rituximab, […]
August 12, 2021

FDA Approves First Drug for Idiopathic Hypersomnia FDA Approves First Drug for Idiopathic Hypersomnia

The US Food and Drug Administration (FDA) has approved an oral solution of calcium, magnesium, potassium, and sodium oxybates (Xywav) for the treatment of idiopathic hypersomnia […]
August 12, 2021

Final Word on SSRI for Post-Stroke Depression? Final Word on SSRI for Post-Stroke Depression?

The antidepressant fluoxetine does not prevent or alleviate post-stroke depression, new findings from a randomized, placebo-controlled trial confirm. Dr Osvaldo Almeida The results suggest the routine […]
August 11, 2021

Diabetes Drugs Tied to Less Amyloid, Slowed Cognitive Decline Diabetes Drugs Tied to Less Amyloid, Slowed Cognitive Decline

Among patients with cognitive impairment, those with diabetes who took dipeptidyl peptidase-4 (DPP-4) inhibitors had less amyloid beta (Aβ) in the brain compared to the patients […]
August 9, 2021

Mobile Stroke Teams Treat Patients Faster, Reduce Disability Mobile Stroke Teams Treat Patients Faster, Reduce Disability

Having a mobile interventional stroke team (MIST) travel to treat stroke patients soon after stroke onset may improve patient outcomes, according to a new study. A […]
August 9, 2021

Flavonoids Dietary ‘Powerhouses’ for Cognitive Decline Prevention Flavonoids Dietary ‘Powerhouses’ for Cognitive Decline Prevention

Eating at least half a serving per day of foods rich in flavonoids — like strawberries, oranges, peppers, and apples — may help lower the risk […]
August 6, 2021

FDA Clears New Enzyme Replacement Therapy for Pompe Disease FDA Clears New Enzyme Replacement Therapy for Pompe Disease

The US Food and Drug Administration (FDA) has approved a new enzyme replacement therapy, avalglucosidase alfa (Nexviazyme, Genzyme), for patients aged 1 year and older with […]
August 6, 2021

Neuroscientist’s Work Earns Three Expressions of Concern Neuroscientist’s Work Earns Three Expressions of Concern

A journal has issued expressions of concern for three papers from 2014 and 2015 by a group at Stony Brook University in New York whose work […]
August 5, 2021

Childhood Reading Problems Linked to Worse Mid-Life Memory Childhood Reading Problems Linked to Worse Mid-Life Memory

Amber John Reading problems in childhood are associated with worse verbal memory in middle age, new research suggests. Specifically, reading problems at age 11 are significantly […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0